Trials / Terminated
TerminatedNCT05594979
Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio-metabolic Risk
An Open-label, Single Center, Single Arm, Clinical Trial to Assess the Consumption Effects of 6 Weeks TOTUM-070 on Lipid Metabolism and Cardiovascular Health in Individuals at Increased Cardio-metabolic Risk
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Valbiotis · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This clinical study aims to assess the efficacy of 6 weeks 2.5g dose of TOTUM-070, a mix of 5 plant extracts, on lipid metabolism and cardiovascular health in individuals at increased cardio-metabolic risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | TOTUM-070 | 2.5-g dose of TOTUM-070 diet supplement; Four capsules per day to consume orally in two intakes |
Timeline
- Start date
- 2022-12-14
- Primary completion
- 2023-09-06
- Completion
- 2023-09-27
- First posted
- 2022-10-26
- Last updated
- 2024-02-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05594979. Inclusion in this directory is not an endorsement.